alzheimers-disease

McDonald MP, Overmier JB (1998) Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer’s disease. Neurosci Biobehav Rev 22(1):99-120. doi: 10.1016/s0149-7634(97)00024-9 PMID: 9491942

Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo YM, Roher AE (1996) Specific domains of ß-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 16:6021-6037. doi: 10.1523/JNEUROSCI.16-19-06021.1996 PMID: 8815885

Related Products: Acetylated LDL-SAP (Cat. #IT-08)

Wiley RG, Berbos T, Deckwerth T, Johnson EM, Lappi DA (1995) Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer’s disease. J Neurol Sci 128:157-166. doi: 10.1016/0022-510x(94)00226-e PMID: 7738592

Related Products: 192-IgG-SAP (Cat. #IT-01)

Okamura H, Kitahamara K, Mons N, Matsumoto Y, Ibata Y, Geffard M (1991) Heterogeneous distribution of L-DOPA immunoreactivity in dopaminergic neurons of the rat midbrain. (eds. Nagatsu T, Fisher A, Yoshida M). In: Basic, clinical, an therapeutic aspects of Alzheimer’s and Parkinson’s diseases 423-426. Plenum Press, NewYork and London. doi: 10.1007/978-1-4684-5844-2_87

Related Products: L-DOPA Rabbit Polyclonal, Conjugated (Cat. #AB-T067)

Loy R, Heyer D, Clagett-Dame M, DiStefano PS (1990) Localization of NGF receptors in normal and Alzheimer’s basal forebrain with monoclonal antibodies against the truncated form of the receptor. J Neurosci Res 27:651-664. doi: 10.1002/jnr.490270426 PMID: 1964180

Related Products: NGFr (ME20.4, p75) Mouse Monoclonal (Cat. #AB-N07)

Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2(8000):1403. doi: 10.1016/s0140-6736(76)91936-x PMID: 63862